Biktarvy, formally known as bictegravir sulfate, represents a potent single-tablet regimen for managing HIV infection. This formula combines three essential antiviral agents: bictegravir, emtricitabine, and tenofovir alafenamide. It works by preventing the virus's ability to copy within the body, significantly lowering the viral burden. For many